Quest Diagnostics Inc Finite-Lived Intangible Asset, Expected Amortization, Year One
Quest Diagnostics Inc (DGX) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $149.00 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-26
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $149.00M.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $154.00M.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $113.00M.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $106.00M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $149.00M 10-K · filed 2026-02-26 |
| 2024-12-31 | $154.00M 10-K · filed 2025-02-20 |
| 2023-12-31 | $113.00M 10-K · filed 2024-02-22 |
| 2022-12-31 | $106.00M 10-K · filed 2023-02-21 |
| 2022-09-30 | $105.00M 10-Q · filed 2022-10-21 |
| 2022-06-30 | $106.00M 10-Q · filed 2022-07-22 |
| 2022-03-31 | $106.00M 10-Q · filed 2022-04-22 |
| 2021-12-31 | $105.00M 10-K · filed 2022-02-28 |
| 2021-09-30 | $102.00M 10-Q · filed 2021-10-22 |
| 2021-06-30 | $102.00M 10-Q · filed 2021-07-23 |
| 2021-03-31 | $98.00M 10-Q · filed 2021-04-23 |
| 2020-12-31 | $101.00M 10-K · filed 2021-02-22 |
| 2020-09-30 | $101.00M 10-Q · filed 2020-10-23 |
| 2020-06-30 | $96.00M 10-Q · filed 2020-07-24 |
| 2020-03-31 | $94.00M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $96.00M 10-K · filed 2020-02-20 |
| 2019-09-30 | $96.00M 10-Q · filed 2019-10-23 |
| 2019-06-30 | $97.00M 10-Q · filed 2019-07-24 |
| 2019-03-31 | $97.00M 10-Q · filed 2019-04-24 |
| 2018-12-31 | $97.00M 10-K · filed 2019-02-21 |
| 2018-09-30 | $90.00M 10-Q · filed 2018-10-24 |
| 2018-06-30 | $88.00M 10-Q · filed 2018-07-25 |
| 2018-03-31 | $87.00M 10-Q · filed 2018-04-20 |
| 2017-12-31 | $82.00M 10-K · filed 2018-02-23 |
| 2017-09-30 | $74.00M 10-Q · filed 2017-10-19 |
| 2017-06-30 | $67.00M 10-Q · filed 2017-07-25 |
| 2017-03-31 | $65.00M 10-Q · filed 2017-04-21 |
| 2016-12-31 | $69.00M 10-K · filed 2017-02-22 |
| 2016-09-30 | $69.00M 10-Q · filed 2016-10-21 |
| 2016-06-30 | $69.00M 10-Q · filed 2016-07-25 |
| 2016-03-31 | $69.00M 10-Q · filed 2016-04-27 |
| 2015-12-31 | $70.00M 10-K · filed 2016-02-26 |
| 2015-09-30 | $72.00M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $71.00M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $71.00M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $85.00M 10-K · filed 2015-02-24 |
| 2014-09-30 | $84.00M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $84.00M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $79.00M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $77.00M 10-K · filed 2014-02-18 |
| 2013-09-30 | $76.66M 10-Q · filed 2013-10-24 |
| 2013-06-30 | $77.38M 10-Q · filed 2013-07-25 |
| 2013-03-31 | $73.85M 10-Q · filed 2013-04-24 |
| 2012-12-31 | $72.98M 10-K · filed 2013-02-27 |
| 2012-09-30 | $78.64M 10-Q · filed 2012-10-24 |
| 2012-06-30 | $78.38M 10-Q · filed 2012-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |